Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, triple-masked, placebo-controlled parallel-arm human subjects clinical
trial investigating the addition of a continuous erector spinae plane nerve block to a
single-injection erector spinae plane block to provide postoperative analgesia following
percutaneous nephrolithotomy. Participants will all receive a single-injection nerve block
and perineural catheter insertion. Following surgery, participants will be randomly allocated
to receive either perineural local anesthetic or normal saline until the second day following
surgery.